semaglutide vs tirzepatide efficacy weight loss of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia Tirzepatide vs semaglutide and liraglutide

Tirzepatide is a synthetic 39-amino acid peptide linked to a C20 fatty acid , designed to activate two metabolic receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)

Addressing these limitations is essential for the successful translation of biologics from the bench to the bedside in cardiovascular care

Combining NAC with selenium supports both the production and the recycling of glutathione

Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure

Obesity is classified as a chronic condition, and Retatrutide is designed for ongoing treatment, similar to blood pressure or cholesterol medication

Relationship between microbiota of the colonic Mucosa vs Feces and symptoms, colonic transit, and methane production in female patients with chronic constipation